Paul Zintl
About Paul Zintl
Paul Zintl is Chief Operating Officer for Partners In Health (PIH) and Senior Advisor for Planning and Finance for the Program in Infectious Disease and Social Change (PIDSC) at Harvard Medical School (HMS). He joined PIH and HMS in January, 2002. He is also currently serving as the chair of the Drug Management Sub-Committee within the Stop TB Partnership.
Prior to joining PIH/HMS, Mr. Zintl was a managing director of J.P. Morgan & Co. in New York, where he worked for 18 years, until 1995. In this capacity, his responsibilities included management, control, analysis, and evaluation of the firm’s trading businesses. After leaving J.P. Morgan, he studied state criminal justice systems and worked as a private consultant for two years. In 1998 he received a Master in Public Administration degree from the John F. Kennedy School of Government at Harvard.
Role(s) / Profession(s)
- Administrator (CEO, COO, President, Executive)
Organization
- Harvard Medical School
- Partners In Health - PIH
- Stop TB Partnership
Work Location(s)
- United States
Paul's Communities
Language(s)
- English
Recent Contributions
-

Paul Zintl started a discussion "National Public Radio Report re XDR-TB" in the MDR-TB Treatment & Prevention community.
here is a 3-minute radio segment reporting on the XDR-TB findings: NPR's "All Things Considered" on Wednesday reported on the study. The segment includes comments from Mitnick; Raviglione; and Jennifer Furin, Partners in Health country director in Lesotho (Knox, "All Things Considered," NPR, 8/6). Audio of the segment is available online at http://www.npr.org/templates/story/story.php?storyId=93355488
-

Paul Zintl started a discussion "James Nachtwey XDR TB photography" in the MDR-TB Treatment & Prevention community.
This new website provides haunting images to raise awareness of the threat of XDR/MDR-TB The issue and the photos| www.XDRTB.org <http://www.xdrtb.org/>
-

Paul Zintl started a discussion "Effective TB and HIV Program Integration?" in the Adherence & Retention community.
In a revised Guide to the Community-Based Treatment of HIV in Resource-Poor Settings, Partners In Health provides an extensive discussion of how to manage TB and HIV co-infection, detailing the prevention and diagnosis of TB in HIV-positive patients, TB therapy for patients needing ART, the choice of regimen, and the monitoring and coordination of services for co-infected patients (see Chapter 2: Initiating a Comprehensive HIV Prevention and Treatment Program: The PIH Model). This Guide can ...
-

Paul Zintl started a discussion "How research can help control tuberculosis" in the MDR-TB Treatment & Prevention community.
How research can help control tuberculosis by R. E. Chaisson, M. Harrington, The International Journal of Tuberculosis and Lung Disease, May 2009 Full text access available at this link: http://www.ingentaconnect.com/content/iuatld/ijtld/2009/00000013/00000005/art00007?token=004e1a822b4b5ed5957b76504c48763f255c235646247a42427c6a332b25757d5c4f6d4e227a97 Tuberculosis (TB) has played a central role in the history of biomedical science from Koch onwards. Research in the nineteenth and twentieth centuries yielded extremely valuable diagnostic, therapeutic and preventive tools for the control of TB. Following the development of shortcourse chemotherapy in the 1970s ...
-

Paul Zintl replied to "DR-TB in Mumbai, India" in the MDR-TB Treatment & Prevention community.
Here is a link to another short video documenting Indus Hospital's community-based treatment for MDR-TB patients in Karachi. http://www.youtube.com/watch?v=K-EQ6BdijFM
Recent Recommendations
- None at this time.
